Side-by-side financials for ENTX and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ENTX | RVMD |
|---|---|---|
| Market cap | - | $31.73 B |
| US-listed rank | - | #448 |
| Revenue (latest FY) | $42.00K | $0.00 |
| Net income (latest FY) | -$11.44M | -$1.13B |
| Net margin | -27235.7% | - |
| SEC filings | 382 | 782 |
In their latest fiscal years, Entera Bio Ltd. reported $42.00K in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Entera Bio Ltd. and Revolution Medicines, Inc., or browse the full rankings.